Maia BiotechnologyMAIA
13F holders, Q3 2025 (September 30)19holders −1
3new positions
4sold out
$1.47avg. 13F price*
At the end of Q3 2025, 19 institutions reported holding Maia Biotechnology Inc. (MAIA) in their 13F filings, down 1 from Q2 2025. 3 opened new positions and 4 sold out. The largest holders were Vanguard Group Inc. ($1.7M), Centric Wealth Management ($713K) and Geode Capital Management, LLC ($418K).
- Company
- Maia Biotechnology Inc.
- CUSIP
- 552641102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $22K |
| Exits | 4 | $56K |
All 13F filers, Q2 2025 → Q3 2025: 162,591 shares bought and 73,142 shares sold, net +89,449 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 19 holders
| Vanguard Group Inc. | 0.00% | Reduce -3.3% | 1,103,145 | $1.7M |
| Centric Wealth Management | 0.16% | Add +0.3% | 574,898 | $713K |
| Geode Capital Management, LLC | 0.00% | Add +22.0% | 271,056 | $418K |
| Marshall Wace, LLP | 0.00% | Add +583.4% | 110,467 | $170K |
| BlackRock, Inc. | 0.00% | Add +1.5% | 104,857 | $161K |
| State Street Corp. | 0.00% | No change | 75,550 | $116K |
| Northern Trust Corp. | 0.00% | No change | 39,032 | $60K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 36,000 | $55K |
| Wealth Enhancement Advisory Services, LLC | 0.00% | No change | 14,800 | $26K |
| Centerpoint Advisory Group | 0.02% | No change | 15,730 | $24K |
| Susquehanna International Group, LLP | 0.00% | New | 11,615 | $18K |
| Osaic Holdings, Inc. | 0.00% | No change | 8,334 | $13K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +118.0% | 4,026 | $6K |
| Curio Wealth, LLC | 0.00% | New | 2,000 | $3K |
| Morgan Stanley | 0.00% | Reduce -83.7% | 832 | $1K |
| MAI Capital Management | 0.00% | No change | 675 | $1K |
| Citigroup Inc. | 0.00% | New | 530 | $816 |
| Jones Financial Companies LLLP | 0.00% | No change | 228 | $369 |
| Bank of America Corp. | 0.00% | Reduce -87.5% | 29 | $45 |
"% of holder's portfolio" is MAIA's weight in each manager's 13F, not the share of Maia Biotechnology Inc. the manager owns.